Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Benef Microbes ; 12(3): 283-293, 2021 Jun 15.
Article in English | MEDLINE | ID: mdl-34030609

ABSTRACT

Escherichia coli Nissle (EcN), a probiotic bacterium protects against several disorders. Multiple reports have studied the pathways involved in cardiac hypertrophy. However, the effects of probiotic EcN against diabetes-induced cardiac hypertrophy remain to be understood. We administered five weeks old Wistar male (271±19.4 g body weight) streptozotocin-induced diabetic rats with 109 cfu of EcN via oral gavage every day for 24 days followed by subjecting the rats to echocardiography to analyse the cardiac parameters. Overexpressed interleukin (IL)-6 induced the MEK5/ERK5, JAK2/STAT3, and MAPK signalling cascades in streptozotocin-induced diabetic rats. Further, the upregulation of calcineurin, NFATc3, and p-GATA4 led to the elevation of hypertrophy markers, such as atrial and B-type natriuretic peptides. In contrast, diabetic rats supplemented with probiotic EcN exhibited significant downregulated IL-6. Moreover, the MEK5/ERK5 and JAK2/STAT3 cascades involved during eccentric hypertrophy and MAPK signalling, including phosphorylated MEK, ERK, JNK, and p-38, were significantly attenuated in diabetic rats after supplementation of EcN. Western blotting and immunofluorescence revealed the significant downregulation of NFATc3 and downstream mediators, thereby resulting in the impairment of cardiac hypertrophy. Taken together, the findings demonstrate that supplementing probiotic EcN has the potential to show cardioprotective effects by inhibiting diabetes-induced cardiomyopathies.


Subject(s)
Cardiomegaly/therapy , Diabetes Mellitus, Experimental/therapy , Diabetic Cardiomyopathies/therapy , Escherichia coli/physiology , Interleukin-6/antagonists & inhibitors , MAP Kinase Signaling System/drug effects , Probiotics/therapeutic use , Animals , Calcineurin/metabolism , Cardiomegaly/metabolism , Cardiomegaly/physiopathology , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/physiopathology , Diabetic Cardiomyopathies/metabolism , Diabetic Cardiomyopathies/physiopathology , Heart Ventricles/drug effects , Heart Ventricles/metabolism , Heart Ventricles/physiopathology , Interleukin-6/metabolism , Janus Kinase 2/metabolism , MAP Kinase Kinase 5/metabolism , Male , Mitogen-Activated Protein Kinase 7/metabolism , Rats , Rats, Wistar , STAT3 Transcription Factor/metabolism , Streptozocin
2.
Cell Death Differ ; 21(8): 1262-74, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24786827

ABSTRACT

Hypertension-induced cardiac hypertrophy and apoptosis are major characteristics of early-stage heart failure. Our previous studies found that the activation of insulin-like growth factor receptor II (IGF-IIR) signaling was critical for hypertensive angiotensin II (ANG II)-induced cardiomyocyte apoptosis. However, the detailed mechanism by which ANG II regulates IGF-IIR in heart cells remains elusive. In this study, we found that ANG II activated its downstream kinase JNK to increase IGF-IIR expression through the ANG II receptor angiotensin type 1 receptor. JNK activation subsequently led to sirtuin 1 (SIRT1) degradation via the proteasome, thus preventing SIRT1 from deacetylating heat-shock transcription factor 1 (HSF1). The resulting increase in the acetylation of HSF1 impaired its ability to bind to the IGF-IIR promoter region (nt -748 to -585). HSF1 protected cardiomyocytes by acting as a repressor of IGF-IIR gene expression, and ANG II diminished this HSF1-mediated repression through enhanced acetylation, thus activating the IGF-IIR apoptosis pathway. Taken together, these results suggest that HSF1 represses IGF-IIR gene expression to protect cardiomyocytes. ANG II activates JNK to degrade SIRT1, resulting in HSF1 acetylation, which induces IGF-IIR expression and eventually results in cardiac hypertrophy and apoptosis. HSF1 could be a valuable target for developing treatments for cardiac diseases in hypertensive patients.


Subject(s)
Angiotensin II/metabolism , DNA-Binding Proteins/antagonists & inhibitors , JNK Mitogen-Activated Protein Kinases/metabolism , Myocytes, Cardiac/metabolism , Receptor, IGF Type 2/metabolism , Sirtuin 1/metabolism , Transcription Factors/antagonists & inhibitors , Animals , Apoptosis/physiology , Female , Heat Shock Transcription Factors , Humans , Male , Myocytes, Cardiac/cytology , Rats , Signal Transduction
3.
Nutr Metab Cardiovasc Dis ; 23(6): 566-73, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22402061

ABSTRACT

BACKGROUND AND AIM: The purpose of this study was to evaluate the effects of exercise training on cardiac apoptotic pathways in obesity. METHODS AND RESULTS: Sixteen lean Zucker rats (LZR) and sixteen obese Zucker rats (OZR) of 5-6 months of age as well as the other sixteen obese rats were subjected to treadmill running exercise for 1 h everyday for 3 months (OZR-EX). After exercise training or sedentary status of the rats, the excised hearts from the three groups were measured by heart weight index, H&E staining, TUNEL assays and Western blotting. Cardiac TUNEL-positive apoptotic cells, the protein levels of TNF alpha, Fas ligand, Fas receptors, Fas-associated death domain (FADD), Bad, Bax, activated caspase 8, activated caspase 9, and activated caspase 3 were higher in OZR than those in LZR. The protein levels of TNF alpha, Fas ligand, Fas receptors, FADD, activated caspase 8, and activated caspase 3 (Fas pathway) and the protein levels of Bad, Bax, Bax-to-Bcl2 ratio, activated caspase 9, and activated caspase 3 (mitochondria pathway) were lower in OZR-EX than those in OZR. CONCLUSION: Cardiac Fas-dependent and mitochondria-dependent apoptotic pathways become more activated in obesity. Exercise training can prevent obesity-activated cardiac Fas-dependent and mitochondria-dependent apoptotic pathways. Our findings demonstrate a new therapeutic effect of exercise training to prevent delirious cardiac Fas-mediated and mitochondria-mediated apoptosis in obesity.


Subject(s)
Apoptosis , Heart/physiopathology , Obesity/physiopathology , Physical Conditioning, Animal , Animals , Blood Pressure , Caspase 3/metabolism , Caspase 9/metabolism , Echocardiography , Fas Ligand Protein/metabolism , Fas-Associated Death Domain Protein/metabolism , Male , Mitochondria, Heart/metabolism , Rats , Rats, Zucker , Tumor Necrosis Factor-alpha/metabolism , bcl-2-Associated X Protein/metabolism , fas Receptor/metabolism
4.
J Oral Pathol Med ; 30(1): 53-8, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11140901

ABSTRACT

MDM2 (murine double minute gene 2) overexpression has been implicated in the pathogenesis of human tumors via inhibition of the p53 tumor suppressor protein. To investigate the potential involvement of MDM2 overexpression in the pathogenesis of oral squamous cell carcinomas (SCCs) in Taiwan, we examined the expression of MDM2 protein and its relationship to p53 protein levels in 52 oral SCCs using antibodies to MDM2 and p53. Of the 52 patients, 36 (69 %) had tumors with positive MDM2 nuclear staining and 32 (61%) had tumors with p53 nuclear staining. Co-expression of MDM2 protein and p53 was detected in 25 (48%) cases; and 9 (17%) tumors showed neither MDM2 protein nor p53 staining. A significant correlation was observed between MDM2 protein and p53 expression in 38 cases with an areca quid (AQ) chewing habit (P=0.032). No significant correlation was found between the degree of MDM2 protein staining and the patients' ages, sex, cancer location, clinical staging, primary tumor TNM status or histological differentiation of SCC at the time of initial presentation. Kaplan-Meier analysis showed that either MDM2 protein expression or co-expression of p53 and MDM2 protein did not relate significantly to patient overall survival. Nevertheless, the high prevalence of MDM2 protein overexpression found in this study suggest that MDM2 may also participate in the carcinogenesis of AQ chewing-associated oral SCCs in Taiwan.


Subject(s)
Areca/adverse effects , Carcinoma, Squamous Cell/etiology , Mouth Neoplasms/etiology , Neoplasm Proteins/biosynthesis , Nuclear Proteins , Plants, Medicinal , Proto-Oncogene Proteins/biosynthesis , Adult , Aged , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/mortality , Female , Genes, p53 , Humans , Immunoenzyme Techniques , Male , Middle Aged , Mouth Neoplasms/genetics , Mouth Neoplasms/metabolism , Mouth Neoplasms/mortality , Mutation , Neoplasm Proteins/genetics , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-mdm2 , Survival Analysis , Taiwan , Tumor Suppressor Protein p53/antagonists & inhibitors , Tumor Suppressor Protein p53/genetics
5.
Oral Oncol ; 36(5): 432-6, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10964049

ABSTRACT

To investigate the mechanisms of areca quid (AQ)-induced carcinogenesis, expression of c-fos and c-jun protooncogenes was examined in human oral mucosal fibroblasts after exposure to areca nut extracts (ANE) or arecoline. We found that treatment of cells with 200 microg/ml ANE or 10 microg/ml arecoline for 1 h induced about three-fold increase in c-jun mRNA levels. This increase was transient and the level of c-jun mRNAs returned rapidly to control levels thereafter. However, ANE and arecoline did not induce c-fos mRNA expression at detectable levels. During AQ chewing, oral mucosal cells are continuously stimulated by ANE and arecoline. Persistent induction of the c-jun protooncogene by ANE and arecoline may be one of the mechanisms in the carcinogenesis of oral squamous cell carcinoma in Taiwan. Furthermore, we observed that pre-incubation of cells with either N-acetyl-cysteine [a glutathione (GSH) precursor] or L-buthionine-S,R-sulfoximine (a specific inhibitor of GSH biosynthesis) had a minimal effect on arecoline-induced c-jun expression. Therefore, arecoline-induced c-jun expression is independent of GSH depletion.


Subject(s)
Areca/adverse effects , Arecoline/adverse effects , Carcinoma, Squamous Cell/chemically induced , Fibroblasts/drug effects , Mouth Neoplasms/chemically induced , Plants, Medicinal , Proto-Oncogene Proteins c-jun/drug effects , Carcinoma, Squamous Cell/genetics , Gene Expression/drug effects , Humans , Mouth Mucosa/drug effects , Mouth Neoplasms/epidemiology , Mouth Neoplasms/genetics , Mutagenicity Tests , Taiwan/epidemiology , Taiwan/ethnology
SELECTION OF CITATIONS
SEARCH DETAIL